NCT01588574已完成2 期
Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia
Medy-Tox1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年8月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Number of adverse events
研究概览
简要总结
The purpose of this study is to determine the Optimal dose for safety and efficacy in the treatment of cervical dystonia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female aged 18~75
- •Have no clinically significant medical condition
- •Cervical dystonia
排除标准
- •Pregnant or lactation
- •Subjects who have been administered the following drugs within the previous 1 month
结局指标
主要结局
Number of adverse events
时间窗: Day 30
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye DiseaseDry Eye DiseaseNCT04084483Kowa Research Institute, Inc.238
招募中
1 期
Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed GlioblastomaGlioblastomaNCT04443010Philogen S.p.A.226
Unknown
2 期
Clinical Study in the Treatment of Patients With Moderate Course of COVID-19COVID-19NCT04842435Microgen376
已完成
3 期
Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)Crohn's DiseaseNCT00805766Tanabe Pharma Corporation39
Unknown
不适用
Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T for Advanced GliomaAdvanced GliomaComplication of Chimeric Antigen Receptor (CAR-T) Cell TherapyNCT05752877Second Affiliated Hospital of Soochow University12